FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michel Varroud-Vial

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

France

Activities & Behaviors

Concepts & Ideas

Procedures

Medical Audits

Co-author Network

Publications

TOP 3
Jean-Michel Chabot; Michel Varroud-Vial
[Organization of systems of care. Channnels and networks of care].
Gérard Mick; Michel Varroud-Vial; Annelyse Lemaitre
[Challenges and future perspectives of healthcare networks].
Sylvia Franc; Dured Dardari; Caroline Peschard; Jean-Pierre Riveline; Magdalena Biedzinski; Beatrix Boucherie; Catherine Petit; Elisabeth Requeda; Frederic Mistretta; Michel Varroud-Vial; Guillaume Charpentier
Can postprandial blood glucose excursion be predicted in type 2 diabetes?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michel Varroud-Vial (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jean-Michel Chabot; Michel Varroud-Vial
[Organization of systems of care. Channnels and networks of care].
La Revue du praticien 2012;62(10):1443-6.
2012: Gérard Mick; Michel Varroud-Vial; Annelyse Lemaitre
[Challenges and future perspectives of healthcare networks].
Revue de l'infirmière 2012;(183):26-7.
2010: Sylvia Franc; Dured Dardari; Caroline Peschard; Jean-Pierre Riveline; Magdalena Biedzinski; Beatrix Boucherie; Catherine Petit; Elisabeth Requeda; Frederic Mistretta; Michel Varroud-Vial; Guillaume Charpentier
Can postprandial blood glucose excursion be predicted in type 2 diabetes?
Diabetes care 2010;33(9):1913-8.
2006: Guillaume Charpentier; Jean-Pierre Riveline; Dured Dardari; Michel Varroud-Vial
Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?
Drugs 2006;66(3):273-86.
2004: Michel Varroud-Vial; D Simon; J Attali; I Durand-Zaleski; L Bera; C Attali; C Letondeur; K Strauss; C Petit; Guillaume Charpentier
Improving glycaemic control of patients with Type 2 diabetes in a primary care setting: a French application of the Staged Diabetes Management programme.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(6):592-8.
2003: Jean-Pierre Riveline; Nicolas Danchin; François Ledru; Michel Varroud-Vial; Guillaume Charpentier
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications.
Diabetes & metabolism 2003;29(3):207-22.
2003: Philippe Passa; Michel Varroud-Vial
[Screening program for foot lesion risk in diabetics].
Soins; la revue de référence infirmière 2003;(674 Suppl):14-5.
2003: Michel Varroud-Vial
[Which quality criteria for diabetic care networks?].
Soins; la revue de référence infirmière 2003;(674 Suppl):4-6.
2001: Michel Varroud-Vial; Guillaume Charpentier; Laurent Vaur; J R Attali; N Balarac; P Cervantes; L Kleinebreil; C Levy-Marchal; P Preiss; C Weisselberg; E Eschwege
Effects of clinical audit on the quality of care in patients with type 2 diabetes: results of the DIABEST pilot study.
Diabetes & metabolism 2001;27(6):666-74.
2001: Jean-Pierre Riveline; J Capeau; J J Robert; Michel Varroud-Vial; I Cerf-Baron; A Deburge; Guillaume Charpentier
Extreme subcutaneous insulin resistance successfully treated by an implantable pump.
Diabetes care 2001;24(12):2155-6.
2000: Guillaume Charpentier; Jean-Pierre Riveline; H Lardoux; E Mathieu; E Requeda; Michel Varroud-Vial
[Silent ischemic cardiopathy: which diabetics to examine?].
Archives des maladies du coeur et des vaisseaux 2000;93 Spec No 4():25-32.
2000: Guillaume Charpentier; Jean-Pierre Riveline; Michel Varroud-Vial
Management of drugs affecting blood glucose in diabetic patients with renal failure.
Diabetes & metabolism 2000;26 Suppl 4():73-85.
2000: Karine Clement; Serge Hercberg; B Passinge; P Galan; Michel Varroud-Vial; Alan R Shuldiner; Brock A Beamer; Guillaume Charpentier; Bernard Guy-Grand; philippe froguel; Christian Vaisse
The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(3):391-3.
1999: Michel Varroud-Vial; P Mechaly; S Joannidis; O Chapiro; S Pichard; A Lebigot; M Moulonguet; C Attali; A Bayle; J Bénier; Guillaume Charpentier
Cooperation between general practitioners and diabetologists and clinical audit improve the management of type 2 diabetic patients.
Diabetes & metabolism 1999;25(1):55-63.